• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Enoxacin distribution in human tissues after multiple oral administration.

作者信息

Malmborg A S, Rannikko S

机构信息

Department of Clinical Microbiology, Huddinge University Hospital, Karolinska Institute, Sweden.

出版信息

J Antimicrob Chemother. 1988 Feb;21 Suppl B:57-60. doi: 10.1093/jac/21.suppl_b.57.

DOI:10.1093/jac/21.suppl_b.57
PMID:3162902
Abstract

Enoxacin was administered to six patients undergoing nephrectomy; 200 mg was given orally twice a day for three days preoperatively. The last dose was given on the morning of the day of operation. Samples of blood, skin, subcutaneous fat, muscle, rib bone, and renal cortex and medulla were taken during the procedure. Urine was collected 24 h preoperatively. The concentrations of enoxacin in the different tissues were measured by an agar-well diffusion method. The mean (24 h) urinary excretion of enoxacin was 62.7% of the daily dose. The concentrations in renal cortex and medulla and muscles exceeded those in serum; the mean tissue/serum concentration ratios were 3.8, 3.2 and 1.4, respectively. The ratios for skin and fat were 0.8 and 0.2, respectively. Only four bone samples were obtained and two of them had no detectable levels. The results indicate that enoxacin may be effective for treatment of skin and soft tissue infections and infections in the upper and lower urinary tract.

摘要

相似文献

1
Enoxacin distribution in human tissues after multiple oral administration.
J Antimicrob Chemother. 1988 Feb;21 Suppl B:57-60. doi: 10.1093/jac/21.suppl_b.57.
2
An evaluation of pelvic tissue concentrations after oral administration of enoxacin.口服依诺沙星后盆腔组织浓度的评估。
J Antimicrob Chemother. 1988 Feb;21 Suppl B:79-85. doi: 10.1093/jac/21.suppl_b.79.
3
Bone penetration of enoxacin in patients with and without osteomyelitis.患有和未患有骨髓炎患者中依诺沙星的骨渗透情况。
Antimicrob Agents Chemother. 1988 Jun;32(6):834-7. doi: 10.1128/AAC.32.6.834.
4
Pharmacokinetics and sputum penetration of enoxacin after twice daily oral dosing for seven days.
J Antimicrob Chemother. 1988 Feb;21 Suppl B:61-6. doi: 10.1093/jac/21.suppl_b.61.
5
The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin.
J Antimicrob Chemother. 1988 Feb;21 Suppl B:87-95. doi: 10.1093/jac/21.suppl_b.87.
6
Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
J Antimicrob Chemother. 1988 Feb;21 Suppl B:49-56. doi: 10.1093/jac/21.suppl_b.49.
7
[Enoxacin concentration in human prostatic tissue].[人体前列腺组织中的依诺沙星浓度]
Hinyokika Kiyo. 1986 Oct;32(10):1471-3.
8
Pharmacokinetics of enoxacin and its penetration into bronchial secretions and lung tissue.依诺沙星的药代动力学及其在支气管分泌物和肺组织中的渗透情况。
J Antimicrob Chemother. 1988 Feb;21 Suppl B:67-77. doi: 10.1093/jac/21.suppl_b.67.
9
Enoxacin treatment of urinary tract infections in elderly patients.依诺沙星治疗老年患者尿路感染
J Antimicrob Chemother. 1988 Feb;21 Suppl B:105-11. doi: 10.1093/jac/21.suppl_b.105.
10
Comparison of difloxacin, enoxacin, and cefazolin for the treatment of experimental Staphylococcus aureus endocarditis.双氟沙星、依诺沙星和头孢唑林治疗实验性金黄色葡萄球菌心内膜炎的比较。
Antimicrob Agents Chemother. 1988 Feb;32(2):262-4. doi: 10.1128/AAC.32.2.262.

引用本文的文献

1
Enoxacin: a reappraisal of its clinical efficacy in the treatment of genitourinary tract infections.依诺沙星:对其治疗泌尿生殖道感染临床疗效的重新评估。
Drugs. 1996 Jan;51(1):137-60. doi: 10.2165/00003495-199651010-00009.
2
Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.依诺沙星。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1988 Jul;36(1):32-66. doi: 10.2165/00003495-198836010-00004.
3
Association experiments with aerobic and anaerobic pathogens: a model of in-vitro susceptibility testing in mixed infections. Activity of enoxacin, clindamycin, and metronidazole.
Infection. 1989 May-Jun;17(3):160-4. doi: 10.1007/BF01644018.
4
Fluoroquinolone antimicrobial agents.氟喹诺酮类抗菌剂。
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.
5
Pharmacokinetic disposition of quinolones in human body fluids and tissues.
Clin Pharmacokinet. 1989;16 Suppl 1:5-24. doi: 10.2165/00003088-198900161-00004.
6
Tissue penetration and clinical efficacy of enoxacin in urinary tract infections.
Clin Pharmacokinet. 1989;16 Suppl 1:32-7. doi: 10.2165/00003088-198900161-00006.